Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04938440 · ClinicalTrials.gov registry record
Assessment of Updated Educational Materials for Instanyl®
A clinical trial of Pain and Cancer Pain, sponsored by Takeda.
- Completed
- Registry status
- 536
- Enrollment target
- 1
- Study location
NCT04938440: Completed study of Pain and Cancer Pain, sponsored by Takeda.
NCT04938440 is a study of Pain and Cancer Pain that has completed, run by Takeda. The registered enrollment target is 536 participants, above the 303-participant average among 374 other Pain trials with a reported enrollment target (77% higher). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04938440, a study of Pain and Cancer Pain, has completed, sponsored by Takeda.
- COMPLETED
- Registry status
- 536 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of the Instanyl study is to learn how much doctors know and understand about Instanyl® before and after they receive updated educational information, including the risks of its unapproved use. In this study, the doctors will complete two surveys: one three months before they receive the updated educational information, and one about six months after they receive this information. They will answer questions about their prescribing behavior plus their knowledge of Instanyl® including any risks.
Conditions Studied
Study Locations (1)
Massachusetts
- Central Contact - Cambridge
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 536 participants |
| Start Date | 2022-02-18 |
| Est. Completion | 2023-02-06 |
What the finished NCT04938440 record still lists
NCT04938440 is an observational study that tracks outcomes without assigning an intervention. The registered 536 participants enrollment target is mid-sized for trials with a published cap, above the 303-participant average among 374 other Pain trials with a reported enrollment target (77% higher).
The record links to 2 conditions, with Pain appearing as the primary indexed condition, and to 0 interventions.
NCT04938440 reports a single indexed study location in Massachusetts.
Frequently Asked Questions
What is clinical trial NCT04938440 about?
NCT04938440 is a clinical study titled "Assessment of Updated Educational Materials for Instanyl®". The purpose of the Instanyl study is to learn how much doctors know and understand about Instanyl® before and after they receive updated educational information, including the risks of its unapproved use. In this study, the doctors will complete two surveys: one three months before they receive the ...
What is the current status of trial NCT04938440?
This trial is currently completed. The enrollment target is 536 participants. The study started on 2022-02-18. Estimated completion is 2023-02-06.
What conditions does trial NCT04938440 study?
This clinical trial studies the following conditions: Pain, Cancer Pain.
Who is sponsoring clinical trial NCT04938440?
This trial is sponsored by Takeda, which has 408 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04938440 being conducted?
This trial has 1 study location across Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Pain
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT04938440's enrollment target sits among peer trials
536 28th of 374 higher than 347 of 374 other Pain trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Pain trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Postoperative Pain After Activation of Irrigant
RECRUITING · NA
-
Neural Mechanisms of Immersive Virtual Reality in Chronic Pain (VR TMD EEG)
RECRUITING · NA
-
Reliability of Pupil Response to Acute Pain
RECRUITING
-
Pain With Dementia
RECRUITING · NA
-
Pain Alleviation With Testosterone in Opioid-Induced Hypogonadism
RECRUITING · Phase 2
-
Defense and Veterans Center for Integrative Pain Management (DVCIPM) Pain Registry Biobank
RECRUITING
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05880004 · 537 participants · NA
Developing a Support Application for Food Pantries (SAFPAS) to Improve Client Access to Healthy Foods & Enhance Emergency Preparedness
- NCT05614739 · 535 participants · Phase 1
FORAGER-1: A Study of LOXO-435 (LY3866288) in Participants With Cancer With a Change in a Gene Called FGFR3
- NCT07091617 · 535 participants · NA
Testing an Enhanced Digital Delivery Model for Inherited Cancer Genetic Testing in Young Adults With Cancer
- NCT03772028 · 538 participants · Phase 3
Primary Cytoreductive Surgery With or Without Hyperthermic Intraperitoneal Chemotherapy (HIPEC)
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI